Clinical Trials Sponsored by Fox Chase Cancer Center

Total 8171 results

Fox Chase Cancer Center

Recruiting

Buprenorphine for Cancer Pain

Cancer-Related Pain

United States
Fox Chase Cancer Center

Recruiting

Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer

Lung Cancer | Non Small Cell Lung Cancer | Small-cell Lung Cancer

United States
Fox Chase Cancer Center

Recruiting

Redefining FOLFIORINOX in Older Pancreatic Cancer Patients

Metastatic Pancreatic Cancer

United States
Fox Chase Cancer Center

Recruiting

Atorvastatin ± Aspirin in Lynch Syndrome Syndrome

Lynch Syndrome

United States
Fox Chase Cancer Center

Suspended

HM-178: Assessing Methods for Improvement in Methotrexate Toxicity Management and Detection of Central Nervous System Involvement of Aggressive Lymphoma

Lymphoma

United States
Fox Chase Cancer Center

Active, not recruiting

Perioperative Risk Study (PRS)

Surgery | Tumors | Primary Neoplasm | Secondary Neoplasm

United States
Fox Chase Cancer Center

Completed

PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer

Unspecified Adult Solid Tumor, Protocol Specific | Advanced Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Recurrent Extrahepatic Bile Duct Cancer | Adult Primary Hepatocellular Carcinoma | Metastatic Extrahepatic Bile Duct Cancer | Stage D Adult Primary Liver Cancer (BCLC)

United States
Fox Chase Cancer Center

Active, not recruiting

Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN)

Urothelial Carcinoma of the Bladder

United States
Fox Chase Cancer Center

Withdrawn

A Pilot Study of Circulating Tumor DNA Adaptive Risk Maintenance Approach for Bladder Cancer (CARMA) (CARMA)

Metastatic Urothelial Carcinoma
Fox Chase Cancer Center

Withdrawn

Sotorasib in KRAS G12C Mutated, Resectable, Stage Ib-IIIA NSCLC

Non-Small Cell Lung Cancer

United States
Fox Chase Cancer Center

Active, not recruiting

Molecular Monitoring With Circulating Tumor DNA and Nivolumab Maintenance

Diffuse Large B Cell Lymphoma

United States
Fox Chase Cancer Center

Active, not recruiting

Study to Assess TOPO2A as a Biomarker for Sensitivity to Doxorubicin/Doxil in Soft Tissue Sarcoma

Soft Tissue Sarcoma

United States
Fox Chase Cancer Center

Withdrawn

Everolimus, Erlotinib Hydrochloride, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Previously Treated With Radiation Therapy

Tongue Cancer | Recurrent Metastatic Squamous Neck Cancer With Occult Primary | Recurrent Salivary Gland Cancer | Recurrent Squamous Cell Carcinoma of the Hypopharynx | Recurrent Squamous Cell Carcinoma of the Larynx | Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity | Recurrent Squamous... and other conditions

United States
Fox Chase Cancer Center

Completed

Bicalutamide With or Without Metformin for Biochemical Recurrence in Overweight or Obese Prostate Cancer Patients (BIMET-1)

Cancer of Prostate

United States
Fox Chase Cancer Center

Terminated

Regorafenib Plus 5-Fluorouracil/Leucovorin Beyond Progression in mCRC

Colorectal Cancer

United States
Fox Chase Cancer Center

Terminated

Combination of Cetuximab, Capecitabine, and Oxaliplatin With or Without Bevacizumab

Colorectal Neoplasms

United States
Fox Chase Cancer Center

Completed

Observation Study of Patients With Non-Small Cell Lung Cancer and Esophageal Cancer Treated With Chemo-Radiation Followed by Surgery

Esophageal Cancer | Lung Cancer

United States
Fox Chase Cancer Center

Completed

A Dose-Escalation Study of Onc201 Administered Every One or Three Weeks in Advanced Solid Tumors and Multiple Myeloma

Multiple Myeloma | Advanced Solid Tumors

United States
Fox Chase Cancer Center

Terminated

Quinacrine-Capecitabine Combinatorial Therapy for Advanced Stage Colorectal Adenocarcinoma

Colorectal Adenocarcinoma

United States
Fox Chase Cancer Center

Terminated

Investigation of Contralateral Arytenoid Sparing IMRT for T1a & T2a Larynx Cancer & Analysis of Post-treatment Laryngeal Function

Laryngeal Neoplasms

United States
Fox Chase Cancer Center

Completed

Intensity-Modulated Radiation Therapy With or Without Decreased Radiation Dose to Erectile Tissue in Treating Patients With Stage II Prostate Cancer

Sexual Dysfunction | Prostate Cancer | Sexuality and Reproductive Issues

United States
Fox Chase Cancer Center

Completed

Feasibility Bowel Dysfunction Program After Low Anterior Resection

Rectal Cancer | Low Anterior Resection

United States
Fox Chase Cancer Center

Terminated

Depletion of Myeloid Derived Suppressor Cells to Enhance Anti PD-1 Therapy

Non Small Cell Lung Cancer Stage IIIB

United States
Fox Chase Cancer Center

Terminated

Development of Real-time Image-guided Radiotherapy

Breast Cancer | Lung Cancer | Skin Cancer

United States
Fox Chase Cancer Center

Terminated

Impact of Ribociclib on Head and Neck Squamous Cell Cancer

Squamous Cell Carcinoma of the Head and Neck

United States
Fox Chase Cancer Center

Completed

Adherence to Survivorship Care Guidelines in Health Care Providers for Non-Small Cell Lung Cancer and Colorectal Cancer Survivor Care

Mucinous Adenocarcinoma of the Rectum | Signet Ring Adenocarcinoma of the Rectum | Stage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Stage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small... and other conditions

United States
Fox Chase Cancer Center

Completed

Genetic Epidemiology Risk Assessment Program or Usual Care in Colorectal Cancer Screening for Healthy Participants

Colorectal Cancer | Healthy, no Evidence of Disease

United States
Fox Chase Cancer Center

Withdrawn

Paclitaxel, Topotecan, and Estramustine in Treating Patients With Metastatic Hormone-Refractory Prostate Cancer

Prostate Cancer
Fox Chase Cancer Center

Completed

Study of Paclitaxel, Carboplatin, and Cetuximab for Advanced Lung Cancer

Carcinoma, Non-Small-Cell Lung

United States
Fox Chase Cancer Center

Recruiting

Adaptive Radiation for Abdominopelvic Metastases

Malignant Neoplasm of Stomach | Neoplasm - Soft Tissue Pelvis Malignant Secondary

United States
Fox Chase Cancer Center

Recruiting

Post-Discharge Risk-Based Management in Patients Undergoing High-Risk Elective Major Cancer Operations (PRS II)

Cancer | Surgery

United States
Fox Chase Cancer Center

Recruiting

Phase I Study in Advanced Malignancies With 5-ALA

Solid Tumor

United States
Fox Chase Cancer Center

Recruiting

Study of Nivolumab and Axitinib in Patients With Advanced Renal Cell Carcinoma

Renal Cell Carcinoma

United States
Fox Chase Cancer Center

Suspended

Organ Preservation in Early Rectal Cancer Patients

Rectal Cancer

United States
Fox Chase Cancer Center

Active, not recruiting

Phase II Trial of Ribociclib and Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS)

Soft Tissue Sarcoma

United States
Fox Chase Cancer Center

Suspended

A Study of Risk Enabled Therapy After Neoadjuvant Immunochemotherapy for Bladder Cancer

Muscle-Invasive Bladder Carcinoma

United States
Fox Chase Cancer Center

Terminated

Study of TAK-228 (MLN0128) in Soft Tissue Sarcomas

Soft-tissue Sarcoma

United States
Fox Chase Cancer Center

Withdrawn

Efficacy of Topical Mitomycin C for Complex Benign Esophageal Anastomotic Strictures

Esophageal Stenosis | Anastomotic Stenosis

United States
Fox Chase Cancer Center

Completed

A Web-Based Multimedia Intervention for Head and Neck Cancer Patients

Cancer of the Head and Neck

United States
Fox Chase Cancer Center

Terminated

Safety and Activity of Digoxin With Decitabine in Adult AML and MDS

Acute Myeloid Leukemia | Myelodysplastic Syndromes

United States
Fox Chase Cancer Center

Completed

A Pilot Study of a Home-Based Walking Intervention for Pancreatic Cancer Patients

Cancer of Pancreas

United States
Fox Chase Cancer Center

Completed

3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Recurrent Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Fox Chase Cancer Center

Terminated

Study of Ixazomib With Pegylated IFN-alpha 2b (pIFN) in Metastatic Renal Cell Carcinoma (mRCC)

Metastatic Renal Cell Carcinoma | RCC

United States
Fox Chase Cancer Center

Completed

A Study of Carboplatin, PLD and Everolimus in Certain Gynecologic Cancer

Fallopian Tube Cancer | Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial Cancer

United States
Fox Chase Cancer Center

Completed

Facilitating Participation in a Prostate Cancer Risk Assessment Program

Prostate Cancer

United States
Fox Chase Cancer Center

Completed

Study of Low-Dose Fractionated Radiotherapy in Patients With Locally Advanced Metastatic Pancreatic Cancer

Metastatic Pancreatic Cancer | Pancreatic Carcinoma Non-resectable

United States
Fox Chase Cancer Center

Completed

Comparative Effectiveness of CTC & OC

Colorectal Cancer

United States
Fox Chase Cancer Center

Completed

Smoking Cessation for Low-Income Pregnant Women (ACS)

Smoking | Pregnancy

United States
Fox Chase Cancer Center

Not yet recruiting

Pacritinib w/ Talazoparib in Pts w/ Myeloproliferative Neoplasms Unresponsive to JAK2 Inhibition

Primary Myelofibrosis | Polycythemia Vera | Chronic Myelomonocytic Leukemia | Essential Thrombocytosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia Myelofibrosis

United States
Fox Chase Cancer Center

Recruiting

Enfortumab Vedotin Schedule De-escalation in Metastatic Urothelial Carcinoma

Urothelial Carcinoma | Metastatic Urothelial Carcinoma | Locally Advanced Urothelial Carcinoma

United States

Clinical Trials Sponsored by Fox Chase Cancer Center

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Togo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations